A Clinical Trial to Evaluate the Corneal Endothelial Health of DED Subjects Treated With Cyclosporine

NCT06329661 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

204

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease

Interventions

DRUG: Cyclosporine ophthalmic solution, 0.1%
DRUG: Saline solution, 0.6%

Sponsor

Novaliq GmbH